DNA-flow cytometric analysis of bladder TCC using paraffin-embedded tissues

Urologia Internationalis

Volumn 60, Issue 4, 1998, Pages 208-215

  Wu, Lujia ^a   Lochhead, Alistair ^b   Yang, Jia Lin ^a   Ow, Kim T ^a   Russell, Pamela J ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Southern Pathology   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Bladder; DNA flow cytometry; Paraffin embedded tissues; Ploidy; Transitional cell carcinoma

Indexed keywords

DNA; PARAFFIN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; BLADDER MUCOSA; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; ENDOSCOPY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; PLOIDIES; PROGNOSIS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 0031688769     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030256     Document Type: Article

References (43)

1. Boring CC, Squires TS, Tong T: Cancer statistics 1993. CA. Cancer J Clin 1993;43:7-26.
2. Hanno PM, Wein AJ: Carcinoma of the bladder, in Wein AJ (ed): A Clinical Manual of Urology. Norwalk, Appleton-Century-Crofts, 1987, pp 297-312.
3. Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP: Biology and management of bladder cancer. N Engl J Med 1990;322:1129-1138.
4. Raghavan D, Huben R: Management of bladder cancer. Curr Probl Cancer 1995;19:1-64.
5. Farsund TM, Hostmark JG, Laerum OD: Relation between flow cytometric DNA distribution and pathology in human bladder cancer. Cancer 1984;54:1771-1777.
6. Wijkstrom H, Granberg-Ohman J, Tribukait B: Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy. J Urol 1985;132:894-898.
7. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-1335.
8. Tribukait B: Flow cytometry in assessing the clinical aggressiveness of genitourinary neoplasms. World J Urol 1987;5:108-122.
9. Lipponen PK, Eskelinen MJ, Nordling S: Progression and survival in transitional cell bladder cancer: A comparison of established prognostic factors, S-phase fraction and DNA ploidy. Eur J Cancer 1991;27:877-881
10. Lieber MM: Prognostic importance of nuclear DNA content measured by flow cytometry for patients with adenocarcinoma of the prostate. Urol Int 1991;47(suppl 1):74-76.
11. Kim YJ, Ngoi SS, Godwin TA, DeCosse JJ, Staiano-Coico L: Ploidy in invasive colorectal cancer. Implication for metastatic disease. Cancer 1991;68:638-641.
12. Mostofi FK, Sobin HL, Torlini H: International Histological Classification of Tumors. Histological Typing of Urinary Bladder Tumours. Geneva, World Health Organization, 1973, vol 10, pp 21-22.
13. Hermanek P, Sobin LH (eds): UICC-International Union Against Cancer. TNM Classification of Malignant Tumors, ed 4. Heidelberg, Springer, 1987, pp 133-135.
14. Yang JL, Crowe PJ, Ow KT, Ham JM, Crouch RJ, Russell PJ: DNA flow-cytometric analysis in colorectal cancer. A comparison of metastasizing and non-metastasizing tumours. J Gastroenterol Hepatol 1996;11:319-324.
15. Wheeless LL, Badalament RA, White RW, Fradet Y, Tribukait B: Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 1993;14:478-481.
16. Weber CJ, Merriam L, Koschitzky T, Karp F, Benson M, Forde K: Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995. Treatment of nude mouse xenografts. Surgery 1989;106:416-422.
17. Chryssochoos JT, Weber CJ, Cohen C, Moore J, DeRose PB, Hagler M, Bray R, Stempora L, Mamiero M, McGarity WC: DNA index and ploidy distinguish normal human parathyroids from parathyroid adenomas and primary hyperplastic parathyroids. Surgery 1995;118: 1041-1049.
18. Lipponen PK, Eskelinen ML, Collan Y, Pesonen E, Ventila T, Sotarauta M, Nordling S: DNA ploidy and S phase fraction in human bladder cancer. Urol Int 1990;45:4-9.
19. Coon JS, Schwartz D, Summers JL, Miller AW III, Weinstein RS: Flow cytometry of deparaf-finized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis. Cancer 1986;57:1594-1601.
20. Jacobsen AB, Fossa SD, Thorud E, Lunde S, Melvik JE, Pettersen EO: DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material. APMIS 1988;96:25-29.
21. Fossa SD, Kaalhus O: The prognostic relevance of nuclear Feulgen DNA in transitional cell carcinoma of the urinary bladder. Eur Urol 1985;11:418-421.
22. Friedlander ML, Hedley DW, Taylor IW, Russell PJ, Coated AS, Tattersall MHN: Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res 1984;44: 397-400.
23. Jacobsen AB, Fossa SD, Lunde S, Melvik JE, Pettersen EO: Flow cytometric DNA measurements in paraffin-embedded bladder carcinoma tissue before and after precystectomy radio-therapy. Radiother Oncol 1987;10:149-155.
24. Devonec M, Darzynkiewicz Z, Kostyrka-Claps ML, Collste L, Whitmore WF Jr, Melamed MR: Flow cytometry of low stage bladder tumors. Correlation with cytologic and cytoscopic diagnosis. Cancer 1982;49:109-118.
25. Wheeless LL, Reader JE, O'Connell MJ, Robinson RD, Cosgriff JM, Fradet Y, Frank IN, Cockett AT: DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells. Cytometry 1991;12:140-146.
26. Darzynkiewicz Z: Molecular interactions and cellular changes during the cell cycle. Pharmacol Ther 1983;21:143-188.
27. Jacobsen AB, Pettersen EO, Amellem O, Berner A, Ous S, Fossa SD: The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy. J Urol 1992;147:34-37.
28. Jacobsen AB, Lunde MD, Ous S, Melvik JE, Pettersen EO, Kaalhus O, Fossa SD: T3/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values. Int J Rad Oncol Biol Phys 1989;17:923-929.
29. Hamano K, Kinjo M, Kumazawa J: Flow-cytometric deoxyribonucleic acid analysis of the human bladder cancers with reference to histopathological findings. Eur Urol 1992;22: 153-157.
30. Colombel MC, Pous MF, Abbou CC, Vanvel-thoven R, Bellot J, Spyratos F, Andrieu C, de Launoit Y, Chopin DK. Computer assisted image analysis of bladder tumour nuclei for morphonuclear and ploidy assessment. Anal Cell Pathol 1994;6:137-147.
31. Gourlay W, Chan V, Gilks B: Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice. A prospective study. Mod Pathol 1995;8:394-397.
32. Shaaban AA, Tribukait B, El-Bedeiwy AF, Ghoneim MA: Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry. J Urol 1990;144: 884-887.
33. Pan ST, Chan LP, Yu KC, Chang MC, Ho WL: A retrospective study of DNA ploidy of transitional cell carcinoma of urinary bladder using flow cytometry. Kaohsiung J Med Sci 1994;10: 22-27.
34. Klein FA, Whitmore WF Jr, Wolf RM, Herr HW, Sogani PC, Staiano-Coico L, Melaned MR: Presumptive down-staging from preoperative irradiation for bladder cancer as determined by flow cytometry. Preliminary report. Int J Rad Oncol Biol Phys 1983:9:487.
35. Wijkstrom H, Granberg-Ohman J, Tribukait B: Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow-cytofluorometric DNA study. Cancer 1984;53:1718.
36. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD: Superficial bladder tumors (stage pTa, grades 1 and 2). The importance of recurrence pattern following initial resection. J Urol 1986;135:920-922.
37. Madgar I, Goldwasser B, Nativ O: Long-term follow-up of patients less than 30 years old with transitional cell carcinoma of the bladder. J Urol 1988;139:933.
38. Wolf H, Hojgaard K: Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new recurrences. Lancet 1983;ii:134-136.
39. Lipponen PK, Collan Y, Eskelinen MJ, Pesonen E, Sotarauta M, Nordling S: Comparison of morphometry and DNA flow cytometry with standard prognostic factor in bladder cancer. Br J Urol 1990;65:589-597.
40. Busch C, Engberg A, Norlen BJ, Stenkvist B: Malignancy grading of epithelial bladder tumours Scand J Urol Nephrol 1975;1:140-143.
41. Ooms ECM, Veldhuizen RW: Argyrophilic proteins of nucleolar organizer region in bladder tumors. Virchows Arch 1989;414:365-369.
42. Heiden T, Strang P, Stendahl U, Tribukait B: The reproducibility of flow cytometric analyses in human tumors. Methodological aspects. Anticancer Res 1990;10:49-54.
43. Hostmark JG, Laerum OD, Farsund T: DNA aberrations of bladder mucosa in patients with transitional cell carcinomas. Scand J Urol Nephrol 1984;18:113-120.